QIAGEN QGEN recently reached a major landmark in the field of tuberculosis (TB) testing. On World TB Day, the company announced that since the lime of its launch, the company’s QuantiFERON blood test ...
Enabling highly automated screening solution for latent tuberculosis in all throughput segments Embedding QuantiFERON assays in the broad assay menu of DiaSorin’s LIAISON analyzers also gives current ...
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis ...
The interferon-gamma release assay for latent tuberculosis infection is designed for use on Diasorin's automated, high-throughput Liaison XL platform.
QIAGEN’s New Generation of QuantiFERON TB Test Gains Chinese Approval and Renewed WHO Recommendation
HILDEN, Germany & GERMANTOWN, Md. & SHANGHAI--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QuantiFERON tuberculosis (TB) testing solution has ...
QuantiFERON-TB Gold Plus plays a critical role in fighting the spread of TB worldwide VENLO, The Netherlands--(BUSINESS WIRE)-- QIAGEN N.V. (QGEN) (NYSE: QGEN; Frankfurt Prime Standard: QIA) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results